PHARMA PATIENT ACCESS WORLD CONGRESS 2025 EUROPE
Improving Patient Access for Better Health Outcomes and Quality of Life
Copthorne Tara Hotel London Kensington, London, UK, London, United Kingdom
Wednesday 11th - Thursday 12th June 2025
KEY INDUSTRY EXPERT SPEAKERS 2025
- Emma Sutcliffe 2nd degree connection Chief Patient Officer, ISPEP
- Robert Mitchell-Thain, CEO, PBC Foundation
- Carole Scrafton, Director & Co-Founder, Flutters and Strutters
- Josie Godfrey, Co-Founder and CEO, Realise Advocacy
- Lindsay Birrell, Co-CEO, Realise Advocacy
- GLENN DARLEY Patient Engagement Lead, EMEA Recordati Rare Disease
- SENIOR REPRESENTATIVE Awaiting for Photo & Bio Recordati Rare Disease
- Victoria Hayes, Director Public Affairs, Northern Cluster, Kyowa Kirin
- Marta Contente, Sr Director, Pipeline Head of Immunology, GHEVO, TEVA
- STEVE CLARK Founder and Patient Advocate Strive for Five
- Katherine Taylor, Patient Advocacy Lead, Pfizer UK
- And much much more...

JOSIE GODFREY
Director, JG Zebra Consulting, Co-Founder and CEO
>Strategic Director, Project HERCULES >Director, JG Zebra Consulting >Former Associate Director, NICE (Highly Specialised Technologies and Topic Selection) >Former Head of Policy, NHS National Specialised Commissioning >International Policy and Patient Advocacy, Sobi

LINDSAY BIRRELL
Co- CEO, Realise Advocacy, Chair of trustees
Former CEO of Metabolic Support UK >Chair of trustees at Medics 4 Rare Diseases. >Former member NHS England Metabolic Clinical Reference Group >Patient Advocacy Group experience of UK routes to access >PPV rep on NHSEi Rare disease Advisory Group

CAROLE SCRAFTON
CEO & Co-Founder Patient Advocacy Organisation
Carole is a patient with chronic and genetic rare disease, Patient Partner, Expert Patient, Patient Speaker, Author and Researcher. She is the CEO & Co-founder of FibroFlutters Patient Advocacy Organisation for chronic / rare illnesses. Helping to develop, nurture and advocate for a multidisciplinary approach to all aspects of medical healthcare so that chronic illness & rare disease patients can receive the type of care and treatments that they need. Carole utilises varying social media platforms to support people with Chronic illness & Rare Disease, #notjustpatients, and with a multi-stakeholder following. A network used for raising disease awareness and sharing as much up to date information. Carole also advocates for patientcentricity, especially patient engagement best practices and the need for patients to be included within research at early development / preclinical phases. She recognises the need to help educate patients about clinical trials and the reason why they should get involved. Recently as a Patient, and with FibroFlutters, was a team member of an initiative to create: ‘How-To guide’. How to implement Patient Engagement into Early Development and Preclinical phases with Patients Focused Medicines Development.

ROBERT MITCHELL-THAIN
CEO
Drawn into the world of PBC with his mother's diagnosis in 1994, Robert has, in one way or another, been involved in PBC advocacy since even before the PBC Foundation was founded in 1996. An experienced and powerful patient advocate, Robert's specialist subject is listening to the patient, and using the patient experience to improve the patient experience. An international leader, presenter, innovator, academic, committee member and author on a number of topics, his driver is to ensure the patient voice, and experience, is front and centre of every potential solution to the challenges they face. An agent for change, he has led various campaigns and innovations to improve the PBC patients' quality of life on a multinational stage.

Emma Sutcliffe
Chief Patient Officer
Biopharma, where she leads a dedicated team of Global Patient Directors and is responsible for continuously improving and inspiring excellence in patient engagement practices across the entire organization including a patient champion network of 180 colleagues working with almost 300 patient organizations. As a Medical Biochemist and Psychotherapist, Emma has dedicated her career to amplifying the patient voice in the research and development of medicines and creating patient solutions; accordingly, Emma is one of the most frequently published and awarded leaders in the sector.

STEVE CLARK
Founder and Patient Advocate
Steve Clark was diagnosed with stage 4 colorectal cancer in 2013 and has since become an active patient advocate. He is a regular speaker for audiences of patients, healthcare professionals, researchers, and industry representatives as well as volunteering with several charities including being a Campaigns Ambassador for Cancer Research UK. Steve is a patient representative to several studies and study groups and has been co-author on a number of papers.
In 2017 he set up www.StriveForFive.org, a not-for-profit organization with the mission to give hope to fellow patients with stage 4 cancer and to advocate for improved care for those with advanced cancer.
He is a business and marketing consultant for the pharmaceutical industry with Redwood Brand Curators and has worked in UK and global pharma for over 35 years in business management and global marketing.
Steve is a former Chairman of the Pharmaceutical Marketing Society and was awarded Healthcare Communications Advocate by Communiqué.

Marta Contente
Sr Director, Pipeline Head of Immunology, GHEVO
Marta is currently the Immunology Pipeline Head at TEVA, where she leads the Immunology Global HEVO team. She oversees the strategic direction of the Global Value Teams and is responsible for enhancing the focus on value assessment and payer needs for pipeline assets.
Before joining TEVA, Marta was a Senior Director of Global Health Economics and Outcomes Research at Bristol Myers Squibb (BMS). She led a team responsible for supporting country HTA submissions and access for Cardiology, Immunology and Neuroscience products. Her responsibilities covered all countries outside of the US. Before this role Marta worked within the BMS global HEOR team across Oncology indications and at the Portuguese affiliate across company portfolio (Virology, Metabolics, Haem and Oncology) Previously to BMS, Marta worked at GSK and Pfizer as Market Access manager (Portugal), as well as at Lundbeck in Global Pricing.
Marta holds a degree in Pharmaceutical Sciences from Lisbon University, a Postgraduate Diploma in Health Economics from University of York and an Executive MBA from AESE - IESE Business School.

Victoria Hayes
Director Public Affairs, Northern Cluster
Vicky has 19 years of experience in government affairs and advocacy, with specific expertise in the pharmaceutical sector across Europe. She has led major campaigns on access to innovative treatments, service redesign and the crucial importance of the patient and public voice in the health debate. As a former Governor of the UK's largest mental health trust and today as a mental health advocate she focuses on health equity across the board. She is passionate about innovation strategies, women’s health and systems thinking.